NP-101 (TQ Formula)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NP-101 (TQ Formula), covering 2025-08-07 to 2025-08-07. Get the full timeline:
Most recent: Clinical Trial Update: NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas [Phase 1]